Abstract
Background
As lung impairment is an indicator of increased morbidity and mortality in patients receiving continuous ambulatory peritoneal dialysis (CAPD), the risk factors associated with impaired lung function are of great significance. The aim of this study is to elucidate the effects of inflammatory biomarkers and dialysis adequacy on pulmonary function, in CAPD patients.
Methods
101 patients undergoing CAPD, 30 CKD5 patients and 30 healthy subjects were enrolled. Spirometry and serum biomarkers were evaluated in each subject. Pulmonary function was compared among patients and control groups. Pearson analysis was used to analyze the correlation between serum biomarkers, dialysis adequacy and pulmonary function.
Results
Lower vital capacity, maximal voluntary ventilation (MVV), forced vital capacity (FVC), peak expiratory flow (PEF), maximal mid-expiratory flow rate (MMEF), and diffusing capacity of the lung for carbon monoxide (DLCO) were observed in the CAPD group (all P < 0.05) when compared with control subjects. DLCO % was negatively correlated with CRP (r = −0.349, P = 0.007) and positively correlated with albumin (r = 0.401, P = 0.002). Total Kt/V was associated positively with MMEF % (r = 0.316, P = 0.019), and MVV % (r = 0.362, P = 0.007). nPNA was positively correlated with FVC % (r = 0.295, P = 0.049) and MMEF % (r = 0.381, P = 0.010).
Conclusion
The results suggest that lung function decline was directly related to higher CRP level, hypoalbuminemia, and dialysis inadequacy. These findings provide the evidence that inflammation and dialysis adequacy play a role in predicting outcomes of CAPD patients with pulmonary impairment.
Similar content being viewed by others
Abbreviations
- CAPD:
-
Continuous ambulatory peritoneal dialysis
- CGN:
-
Chronic glomerulonephritis
- DN:
-
Diabetic nephropathy
- RPGN:
-
Rapidly progressive glomerulonephritis
- CIN:
-
Chronic interstitial nephritis
- NS:
-
Nephrotic syndrome
- VRKD:
-
Vasculitis-related kidney damage
- PD:
-
Peritoneal dialysis
- ESRD:
-
End-stage renal disease
- CRP:
-
C-reactive protein
- VC:
-
Vital capacity
- FVC:
-
Forced vital capacity
- MVV:
-
Maximal voluntary ventilation
- FEV1 :
-
Forced expiratory volume in the first second
- PEF:
-
Peak expiratory flow
- MMEF:
-
Maximal mid-expiratory flow rate
- DLCO:
-
Diffusing capacity of the lung for carbon monoxide
- Alb:
-
Albumin
- ESR:
-
Erythrocyte sedimentation rate
- Kt/V:
-
Renal urea clearance index
- CCR:
-
Creatinine clearance rate
- rGFR:
-
Residual glomerular filtration rate
- nPNA:
-
Normalized protein equivalent of nitrogen appearance rate
References
Turcios NL. Pulmonary complications of renal disorders. Paediatr Respir Rev. 2012;13:44–9.
Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgarde F. Lung function and cardiovascular risk—relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106:2555–60.
Razeghi E, Parkhideh S, Ahmadi F, Khashayar P. Serum CRP levels in pre-dialysis patients. Ren Fail. 2008;30:193–8.
Balasubramanian VP, Varkey B. Chronic obstructive pulmonary disease: effects beyond the lungs. Curr Opin Pulm Med. 2006;12:106–12.
Sin DD, Man SFP. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol. 2007;85:141–7.
II. NKF-K/DOQI Clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis. 2001; 37: S65–S136.
Bergstrom J, Furst P, Alvestrand A, Lindholm B. Protein and energy-intake, nitrogen-balance and nitrogen losses in patients treated with continuous ambulatory peritoneal-dialysis. Kidney Int. 1993;44:1048–57.
Bergstrom J, Heimburger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int. 1998;18:467–73.
Tang X, Wang Y, Yang L, Yuan Y. The influence of peritoneal dialysis on the pulmonary function of patients with end-stage renal disease. J West China U Med Sci. 2002;33:123–46.
Hancox RJ, Poulton R, Greene JM, Filsell S, McLachlan CR, Rasmussen F, Taylor DR, Williams MJ, Williamson A, Sears MR. Systemic inflammation and lung function in young adults. Thorax. 2007;62:1064–8.
Bolton CE, Schumacher W, Cockcroft JR, Timpson NJ, Smith GD, Gallacher J, Rumley A, Lowe GD, Ebrahim S, Shale DJ, Ben-Shlomo Y. The CRP genotype, serum levels and lung function in men: the caerphilly prospective study. Clin Sci. 2011;120:347–55.
Jiang R, Burke GL, Enright PL, Newman AB, Margolis HG, Cushman M, Tracy RP, Wang Y, Kronmal RA, Barr RG. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol. 2008;168:602–10.
Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I, Neukirch F, Zureik M. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Resp Med. 2006;100:2112–20.
Olafsdottir IS, Gislason T, Gudnason V, Benediktsdottir B, Olafsson I, Aspelund T, Thjodleifsson B, Janson C. CRP is associated with lung function decline in men but not women: a prospective study. Resp Med. 2013;107:91–7.
Higashimoto Y, Iwata T, Okada M, Hiroaki S, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Resp Med. 2009;103:1231–8.
Rasmussen F, Mikkelsen D, Hancox RJ, Lambrechtsen J, Nybo M, Hansen HS, Siersted HC. High-sensitive C-reactive protein is associated with reduced lung function in young adults. Eur Respir J. 2009;33:382–8.
Alexeeff SE, Litonjua AA, Sparrow D, Vokonas PS, Schwartz J. Statin use reduces decline in lung function—VA normative aging study. Am J Respir Crit Care Med. 2007;176:742–7.
Kuhlmann A, Olafsdottir IS, Lind L, Sundstrom J, Janson C. Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study. BMC Geriatr. 2013;13.
Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. Jama J AM Med Assoc. 2013;309:2353–61.
Ahmadi-Abhari S, Kaptoge S, Luben RN, Wareham NJ, Khaw K-T. Longitudinal association of C-reactive protein and lung function over 13 Years The EPIC-norfolk study. Am J Epidemiol. 2014;179:48–56.
Feng J, Ni SS, Zhou J. Research of C-reactive protein and endothelial cell activation factor change in chronic obstructive pulmonary disease. Chin J Nauti Med Hyper. 2009;16:284–6.
Liu WJ, Liang R. Correlation study of detection of serumhs-CRP, TNF-α and IL-6 to lung function and life quality in COPD patients. J Clin Pulm Med. 2013;18:616–7.
Wynants M, Quarck R, Ronisz A, Alfaro-Moreno E, Van Raemdonck D, Meyns B, Delcroix M. Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2012;40:886–94.
Faubel S. Pulmonary complications after acute kidney injury. Adv Chronic Kidney Dis. 2008;15:284–96.
Feng C, Wang YJ, Tang H. Effects of hemodialysis on pulmonary function in patients with uremia. Med J West China. 2009;21:390–1.
Bloembergen WE. Cardiac disease in chronic uremia: epidemiology. Adv Ren Replace Ther. 1997;4:185–93.
Rubin LJ. Current concepts—primary pulmonary hypertension. N Engl J Med. 1997;336:111–7.
Tarrass F, Benjelloun M, Medkouri G, Hachim K, Benghanem MG, Ramdani B. Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis. Hemodial Int. 2006;10:356–9.
Giuseppe E, Rocco T, Vincenzo P, Claudia T, Maurizio G, Giovanni GB, Carmine Z. Pulmonary congestion and physical functioning in peritoneal dialysis patients. Perit Dialysis Int. 2012;32:531–53630.
Tao Y, Wang YJ, Yang SM. Measurement of respiratory excitability and respiratory muscle strength in uremic patients. China Pratic Med. 2001;3:4–6.
Souza dos Santos Simon MI, Drehmer M, de Abreu e Silva FA, Hoffmann A, Druck Ricachinewsky C, de Fonseca Andrade Procianoy E, Scattolin I, Saldanha Menna Barreto S. Association of nutritional status, plasma, albumin levels and pulmonary function in cystic fibrosis. Nutr Hosp. 2011; 26: 1322–27.
Cueto-Manzano AM, Espinosa A, Herna´ndez A, Correa-Rotter R. Peritoneal transport kinetics correlate with serum albumin but not with the overall nutritional status in CAPD patients. Am J Kidney Dis. 1997;30:229–36.
Shioya M, Yoshida T, Kasai K, Furuya R, Kato A, et al. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients. Nephrology. 2013;l8:539–544.
Acknowledgements
This study was supported by the project of Annual Research Project of Anhui Province (NO. 1208085QH172) and Key Lab of Geriatric molecular medicine of Anhui Province. We are grateful to Medjaden Bioscience Limited for assisting in the preparation of this manuscript. This study was also supported by the Natural Science Foundation of China (NO. 81170030, 81270082 and 81300027), National Education Ministry of China (NO. 20113420110006), Annual Research Project of Anhui Province (NO. 10021303028) and Key Lab of Geriatric molecular medicine of Anhui Province (1206c0805028).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Additional information
P. Zhang, H. -M. Wu, Q. -Y. Shen, X. -M. Qi contributed equally to this work.
About this article
Cite this article
Zhang, P., Wu, HM., Shen, QY. et al. Associations of pulmonary function with serum biomarkers and dialysis adequacy in patients undergoing peritoneal dialysis. Clin Exp Nephrol 20, 951–959 (2016). https://doi.org/10.1007/s10157-016-1244-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-016-1244-1